TP53 and cancer: In particular, the authors demonstrated that, while the glycolytic changes induced by TP53 mutations can be kept consistent in cancer cells, the pathways of mitochondrial energy metabolism are influenced by the type of TP53 mutant: some cause an increase, and others cause a decrease [39].